From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q4 2022 call → NOWe need to determine if management describes the company recently crossing from candidate to approved/specified/listed status inside buyers' systems, and that this is new enough that most volume is ahead. Looking at the transcript, management discusses rubber contract negotiations for 2023-2024. They mention that over 50% of tire volume will be on multiyear contracts. They say "Our progress reflects the customer's value, our dependability and quality, and that the global supply demand dynamics continue to work in our favor." They also mention "Based on pricing alone, we expect rubber gross profit per tonne to increase $80 to $100 in 2023." They talk about supply demand tightness. But is this about being placed into a buyer's system as an approved supplier? Multiyear contracts are a form of commitment, but are they described as a new access status that changes the friction of buying? The transcript says "we made substantial progress in the 2023 to 2024 rubber negotiation cycle for price, volume and terms." They say "over 50% of our tire volume will be on multiyear contracts." This is a contractual arrangement, not necessarily a listing in a procurement system. However, multiyear contracts do reduce the need to re-argue each order, but they are still negotiated contracts. The question asks about being an approved, specified, listed, qualified, registered, reimbursed, or pre-authorized choice inside buyers' own systems. Multiyear contracts are a form of that? Possibly, but the transcript does not explicitly say that the company has been added to a supplier list or that it is now a default. It says they have multiyear contracts, which is a business relationship. The question says "NO if the only access described is ordinary selling relationships, routine reseller/distribution agreements, or standard customer wins where each order still must be individually persuaded." Multiyear contracts are more than that, but are they described as a new status that unlocks future volume? They say "we expect rubber gross profit per tonne to increase $80 to $100 in 2023" based on pricing. They also say "we are confident in this" regarding mid-cycle EBITDA of $500 million. But do they convey that this access is new and most volume is ahead? They say "we made substantial progress" and "over 50% of our tire volume will be on multiyear contracts." That suggests a recent change.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.